Skip to main content
PLOS One logoLink to PLOS One
. 2023 Jun 2;18(6):e0286583. doi: 10.1371/journal.pone.0286583

Status exploration and analysis of regional hospice and palliative care networks in Germany: A protocol for a mixed-methods study

Sven Schwabe 1,*, Christoph Buck 2,3, Franziska A Herbst 1, Tanja Schleef 1, Stephanie Stiel 1, Nils Schneider 1
Editor: Stefan Grosek4
PMCID: PMC10237382  PMID: 37267272

Abstract

Background

Multi-professional cooperation between healthcare providers is a key quality criterion of hospice and palliative care. While hospice and palliative care networks can support cooperation on a local level, opportunities for wider cooperation through the establishment and development of regional hospice and palliative care networks in Germany have not yet been explored systematically.

Aims

The HOPAN study aims at: (1) identifying regional hospice and palliative care networks in Germany, (2) analysing these networks using an adapted quality assessment tool, and (3) proposing setting-sensitive recommendations for network development and exploring the benefits of these recommendations.

Methods

HOPAN is a prospective, observational, mixed-methods study comprising three work packages (WPs). In WP1, the stock of regional hospice and palliative care networks in Germany will be identified via database, literature, and internet research. In WP2a, focus groups will be conducted to adapt an existing maturity model for healthcare networks to regional hospice and palliative care networks. In WP2b, a questionnaire will be sent to each identified regional hospice and palliative care network to gain insight into their structure and status of development. In WP2c, group discussions will be conducted to develop setting-sensitive recommendations for these networks. Finally, in WP3, these recommendations will be sent to all participating hospice and palliative care networks, and the benefits of the recommendations will be evaluated via a questionnaire.

Discussion

Empirically developed setting-sensitive recommendations should enable the systematic establishment and management of regional hospice and palliative care networks in Germany, considering the specific needs and potential of each network. The study findings are expected to improve the overall development of hospice and palliative care services.

Trial registration

The study was prospectively registered in the German Clinical Trials Register (Deutsches Register Klinischer Studien) (Registration N° DRKS00030629; date of registration: 02 November 2022). The study is searchable under the International Clinical Trials Registry Platform Search Portal of the World Health Organization, under the German Clinical Trials Register number.

Introduction

Until recently, some federal states in Germany promoted hospice and palliative care networks on a voluntary basis; however, most networks were financed by the donations and fees of network members [15]. To improve on this situation, in 2021, the German legislature passed a new law (Gesetz zur Weiterentwicklung der Gesundheitsversorgung/GVWG) providing for the promotion of regional hospice and palliative networks [6]. The aim of this legislation is to improve multi-professional and cross-sectoral cooperation in hospice and palliative care at a regional level, via network coordinators, funded by statutory health insurance [7]. Specifically, coordinators are tasked to: (a) support cooperation and coordination between network members, (b) support joint public relations, (c) initiate and organise further and advanced training programmes, (d) organise regular network meetings, and (e) cooperate with other regional counselling services [8]. The networks should include all providers of general and specialised palliative care in the inpatient and outpatient setting. In Germany, the focus of hospice care is on psychosocial and bereavement support. Hospice care takes place in inpatient hospices, hospice day clinics and outpatient hospice services, which should be integrated into the networks [9].

A comprehensive overview of regional hospice and palliative care networks in Germany is lacking. To date, only two smaller surveys at the level of individual federal states have been conducted [3, 5]. One study published regional recommendations for the implementation and coordination of hospice and palliative care networks [10], showing that the investigated networks differed considerably regarding their stages of development, organisational structures, fields of activity and working methods [4].

In hospice and palliative care, healthcare providers and volunteers must collaborate to improve the quality of life of patients and their families [11]. Cooperation between providers in care networks enables a seamless interplay of all healthcare professionals and volunteers, thereby improving the continuity of patient care [12, 13].

On a regional level, collaboration between healthcare providers in hospice and palliative care seems to positively impact individual casework [14]. According to the literature, regional networks may increase the number of personal meetings between healthcare providers and increase members’ willingness to cooperate [15]. Hence, regional networks may improve inter-professional communication among healthcare providers, evoke confidence in action, reduce stress among employees, ensure the early integration of psychosocial and spiritual support, and reduce the number of hospital admissions [16]. They may also promote joint initiatives for the further development of local hospice and palliative care services and improve the organisation of patient-centred care [14, 15].

Until recently, the establishment and development of regional hospice and palliative care networks in Germany was largely unsystematic. These networks were not integrated into the German healthcare system and structural standards and quality indices for network collaboration and coordination were lacking.

Materials and methods

Study aim

The project “HOPAN–Status exploration and analysis of regional hospice and palliative care networks using an adapted quality assessment tool” has the following three objectives:

  1. to identify regional hospice and palliative care networks in Germany,

  2. to analyse these networks using an adapted quality assessment tool, and

  3. to propose setting-sensitive recommendations for further network development and to explore the benefits of these recommendations.

Design

HOPAN is a prospective, observational, mixed-methods study organised into three working packages (WPs). The study protocol adheres to STROBE guidelines [17]. WP1 will involve the identification of regional hospice and palliative care networks in Germany via database, literature and internet research. The findings will provide an overview of the number and regional distribution of hospice and palliative networks in Germany.

In WP2a, an existing maturity model for healthcare networks, developed within the INDiGeR research project, will be adapted to accommodate the structures and contents of the identified regional hospice and palliative care networks [18]. The INDiGeR research aimed at identifying the most relevant dimensions of successful network management and developing general recommendations for the implementation and improvement of healthcare and service networks. The project identified four key dimensions of network management: (a) infrastructure, (b) governance, (c) promotion, and (d) moderation (see Fig 1).

Fig 1. Key dimensions of network management from the INDiGeR project [18] (authors’ own translation into English).

Fig 1

The maturity model focuses on the common provision of services from a single network perspective. This methodological tool will be adapted for application to hospice and palliative networks.

In WP2a, a group of experts will be formed on the basis of the survey results (WP1) with the leaders (e.g. coordinators, moderators) of hospice and palliative care networks in Germany and other network experts. Expert group workshops will examine the extent to which the maturity model should be supplemented and modified to accommodate hospice and palliative care networks, and how the four relevant network dimensions (i.e. infrastructure, moderation, governance, promotion) should be specified and operationalised. This specified and adapted maturity model will form the basis for the model-based network analysis in WP2b.

In WP2b, the adopted maturity model for regional hospice and palliative care networks will be operationalised into questionnaire items. Subsequently, an online survey will be administered to all of the identified networks. The survey is expected to comprise three sections:

  1. A general section on the networks’ basic and structural data (e.g. year of founding, number of partners, participating care actors, number of meetings per year).

  2. A specific section on the model-based network evaluation, focussing on network dimensions and the degrees identified in WP2a (e.g. for network moderation: role understanding and responsibility, intensity of cooperation, communication, services offered to network members, network culture). Specific items will be associated with each sub-dimension, graded in four levels (e.g. initial, structured, established, optimised). Based on the results, a developmental status will be assigned to each dimension.

  3. A retrospective section on good practice and experiences of network development. Each dimension or sub-dimension will be specifically queried, to generate practical examples for the development of recommendations in WP2c.

In WP2c, four expert workshops with the abovementioned network leaders and coordinators (n = 10) will be conducted to develop setting-sensitive recommendations for regional hospice and palliative care networks, on the basis of the results from WP2b.

In WP3, the recommendations arising out of WP2c will be disseminated to individual networks and usability will be evaluated. Each network surveyed in WP2b will receive setting-sensitive, individual recommendations, according to the network’s maturity level. Additionally, each network will receive a link to a quantitative, standardised, online questionnaire to evaluate the utility of the recommendations. This questionnaire will be developed a priori by the research team and will contain questions on the usefulness of the recommendations in their respective dimensions, as well as the actual and planned implementation of the recommendations. The link to the online questionnaire will be sent to the networks using the survey software SoSciSurvey (SoSci Survey GmbH, 2006–2022). The primary aim will be to explore the relevance and feasibility of the setting-sensitive recommendations. Finally, the maturity model and its level-specific recommendations will be adapted in accordance with the survey results and prepared for regional hospice and palliative care networks, so it can be used by: (a) further regional hospices and networks for the purpose of self-assessment and (b) health insurance providers for the purposes of quality assessment and reporting.

Study population and data collection

In WP1, all regional hospice and palliative care networks in Germany will be identified as completely as possible. The total stock of such networks in Germany is currently unknown. Hence, the size of this population can only be estimated. Based on the identified hospice and palliative care networks in Lower Saxony [19] and Bavaria [20], a total of 150 networks in Germany is estimated. Data will be collected via internet and literature research, supplemented by a search of national databases, such as the publicly accessible palliative care portal [21], the “Wegweiser Hospiz- und Palliativversorgung Deutschland” [22], and partly available lists of health ministries and state coordination offices. Network names, contact details, regions, and other relevant and available information (e.g. year of founding, legal formation, sponsorship) will be recorded.

The group of experts, which will be set up in WP2a, will include leaders (n = 10; e.g. coordinators, moderators) of hospice and palliative care networks in Germany and other network experts from hospice and palliative care facilities in Germany. Participating network leaders (n = 7–8) will be selected from the group of networks identified in WP1. The selection will follow the maximum variation sampling strategy, based on criteria that have not yet been defined (e.g. size, duration of existence, degree of professionalisation). Moreover, a small number of experts (n = 2–3) will be recruited from the group of network members, based on the suggestions of cooperating German professional hospice and palliative care associations. If experts decline to participate in the study, the expert group will be supplemented on the basis of the same sampling criteria.

A total of n = 5 expert workshops are planned, each involving n = 10 of the abovementioned leaders and coordinators. Four of these meetings will be conducted as online video conferences. The first workshop will explore the extent to which the structure of the INDiGeR maturity model should be augmented and modified to accommodate hospice and palliative care networks. Members of the research team will send literature on the maturity model to participants prior to the workshop, and then present the model to participants at the workshop. The subsequent three workshops will aim at concretising and operationalising the assumed relevant network dimensions (i.e. infrastructure, moderation, governance, promotion) for regional hospice and palliative care networks. The documented results of the workshops will be compiled, reflected upon, discussed, and integrated by the research team and further developed into a maturity model for regional hospice and palliative care networks. The developed model will then be presented to the experts for their feedback in a further online workshop. In the expert workshops, established methods for moderating group discussions (e.g. card queries, World Cafe) will be used. Each workshop will be 3 hours in duration, and will be audio recorded and transcribed verbatim.

In WP2b, the respective leaders/coordinators of an estimated n = 150 hospice and palliative care networks will be sent an online survey. A response rate of 70% is expected, and thus n = 105 valid data sets to include in the analysis. Notwithstanding this calculated response rate, the aim will be to include as many as possible of the networks identified in WP1, in order to increase statistical power, especially for the more detailed network analysis.

In WP2c, expert workshops (n = 4) with the abovementioned network leaders/coordinators (n = 10) will be conducted to develop setting-sensitive recommendations for regional hospice and palliative care networks. For this purpose, the results of the network analysis for the individual dimensions of the maturity model (including the level-specific locations of the networks) will be presented as impulse speech. In group discussions, participants will develop specific recommendations for the further development of networks for each development level and sub-dimension. Each workshop will be 3 hours in duration, and will be audio recorded and transcribed verbatim. An overlap of participants in WP2a and WP2c will promote participants’ long-term commitment to and identification with the project.

In WP3, all networks that participated in WP2b will be administered a quantitative online survey. A total of n = 105 participating networks in WP2b and a response rate of 70% are assumed. Hence, 74 valid data sets are expected for inclusion in the analysis. Respondents will indicate on a 4-point verbal rating scale the extent to which they deem the individual recommendations relevant and feasible for their own network. They will also be afforded the opportunity to make suggestions for improvement, via free text comments.

Inclusion and exclusion criteria

WP2a and WP2c will include leaders (e.g., coordinators, moderators) of hospice and palliative care networks in Germany and other network experts from the field of hospice and palliative care in Germany. All participants will be aged ≥18 years and have theoretical and/or practical knowledge and/or experience of hospice and palliative care networks in Germany.

After receiving detailed information about the type, content, and purpose of the study and their participation, experts will provide written informed consent to participate. Experts of all genders and ethnic backgrounds will be invited to participate.

Experts will be excluded from the study if they are insufficiently proficient in the German language to join group discussions and/or if they do not consent to participate.

Ethical considerations

The study was approved on 20 August 2022 by the Ethics Committee of Hannover Medical School (N° 10424_BO_S_2022) and the appointed data protection officer of Hannover Medical School. Prior to administering the questionnaire, the researchers will provide eligible participants with detailed information about the study type, content, purpose, and duration.

All study participants will be informed in detail, orally and in writing, about the project aims and expected outputs, before confirming their participation in the project. Participation will only be possible when the individual explicitly agrees to participate in the study and signs a written consent form. Each participant will have the right to refuse or discontinue participation at any time without providing any reasons for doing so.

The study results (e.g. transcripts) will be stored pseudonymously on the secure servers of the MHH, in order to ensure personal data protection and prevent the results from being linked to individual participants.

Data analysis

The data analysis will aim at describing the current stock of regional hospice and palliative care networks in Germany and determining setting-sensitive recommendations for the further development of these structures.

In WP1, data from the national database, internet, and literature searches will be transferred to a Microsoft Excel 2016 spreadsheet. Key characteristics of the identified institutions will be documented in a template, according to availability (e.g. network name, district, federal state, contact person, contact address, legal formation, year of founding, region [urban/rural], and number of members). Additionally, quantitative data will be analysed descriptively using IBM SPSS Statistics 27 (SPSS Inc., Chicago, IL, USA) for Windows. The survey will provide an overview of the number and regional distribution of hospice and palliative care networks in Germany.

In WP2a, the expert workshops (n = 5) with n = 10 participants (each) will be audio recorded and transcribed verbatim. Visual data, including the findings of card queries and World Cafes, will be photographed. Both oral and visual data will be analysed according to qualitative content analysis, using MAXQDA 2022 (VERBI Software Consult Sozialforschung GmbH, 1989–2022) [23].

In WP2b, the results of the online survey will be analysed descriptively and with frequency tables, using IBM SPSS Statistics 27. If possible, cluster analyses will be conducted to identify similar structures and different network types (e.g. “public/outward-oriented networks” vs. “member/inward-oriented networks”). Free text answers regarding network management will be inductively categorised, summarised, and evaluated using frequency counting.

In WP2c, the transcripts of the expert group discussions will be analysed according to qualitative content analysis, using MAXQDA 2022. A deductive coding procedure will be used, whereby the levels and sub-dimensions of the maturity model specified in WP2a will function as categories. The research team will review the recommendations in terms of coherence and adapt the wording as needed.

In WP3, quantitative data from the online survey will be analysed descriptively, using IBM SPSS Statistics 27. Free text comments will be analysed descriptively, in terms of content.

Fig 2 provides an overview of the mixed-methods study design across the three WPs. The figure illustrates the methods that will be used to develop setting-sensitive recommendations for regional hospice and palliative care networks in Germany.

Fig 2. HOPAN study design.

Fig 2

Expected results

The main expected results are: (1) an overview of existing regional hospice and palliative care networks in Germany, (2) a maturity model for regional hospice and palliative care networks, (3) a model-based network analysis, and (4) setting-sensitive recommendations for the further development of each network. These findings will contribute to the further development of hospice and palliative care services in Germany, on a wider scale.

Study risks

Access to experts and leaders/coordinators of hospice and palliative care networks can be difficult, depending on their workloads and basic attitudes towards and experience with research projects. Hence, reaching the required number of participants may be a methodological challenge. However, achievement of the case numbers seems feasible, since the majority of the WPs involving leaders/coordinators are based on a qualitative research design, and the case numbers were calculated generously. Also, recruitment will be broad.

For the nationwide identification of regional hospice and palliative care networks, cooperative agreements will be made with all of the relevant associations, ensuring access to the relevant databases [22] and network coordinators. In addition, the status analysis will be supplemented by an independent internet search for each federal state. This staggered procedure will ensure that networks are comprehensively identified and addressed. Furthermore, it is expected that the networks will have an intrinsic interest in participating in the project, in order to benefit from the specific recommendations for network development.

Study status and timeline

The HOPAN study is scheduled to start in January 2023, spanning 2 years.

Discussion

Limitations of the study design

The HOPAN study will use a broad research strategy to identify regional hospice and palliative care networks in Germany. However, since new funding opportunities for hospice and palliative care networks were established in April 2022, it is expected that further networks will emerge during the course of the study. The research team will ask all partners to inform them of all emerging networks, in order for these networks to be invited to participate in the study. Nonetheless, a complete survey of all existing networks cannot be guaranteed.

The network analysis will be based on qualitative and quantitative data collected from network coordinators and leaders. Thus, the HOPAN study will specifically reflect the perspectives of these network coordinators and leaders, while omitting the perspectives of other network members, as well as patients and family caregivers. Hence, the study will not be able to evaluate the impact of hospice and palliative care networks on the quality of patient care.

Dissemination and implementation

To promote the accessibility and longevity of the research data and results, the research team will report the study findings in a comprehensive and transparent manner. Regardless of the findings, the research team will produce national and international congress presentations and peer-reviewed publications (published as open access, where possible). Data files with no personal identifying information will be kept after the study completion. In accordance with the American Psychological Association Code of Ethics, Sec. 8.14, “Sharing Research Data for Verification” [24], the study leader will not withhold any unidentifiable data from other researchers who wish to verify the conclusions of the author(s). Researchers who wish to use HOPAN study data to answer new research questions must obtain prior permission from the research group and author(s).

The results may be used directly by eligible networks in Germany (of which there are approximately 400) to improve their network structure and work. Based on the level-specific recommendations, each network will receive suggestions for further development and optimisation, tailored to the individual network status, thus enabling a process-oriented network development geared towards regional structures. The specified maturity model will ensure that all relevant network dimensions are considered. The recommendations are expected to support network coordinators’ efforts to specify their field of activity, and to be used for training and the further education of network leaders and coordinators in hospice and palliative care. The project results may also be used for quality assessment and quality management in regional hospice and palliative care networks.

Conclusion

The present study protocol explains the purpose, significance, and scope of the mixed-methods study HOPAN, as well as its study design. The recommendations developed in this study are expected to optimise the establishment and development of regional hospice and palliative care networks in Germany, by ensuring better network coordination and promoting the development of regional hospice and palliative care structures. This improved networking is likely to have a positive effect on the quality of care in hospice and palliative care. The adapted maturity model will be initially published in digital form. If necessary, the model will be further developed in a follow-up project into a digital self-assessment tool for networks, which will automatically show level-specific recommendations relevant to the self-location. In addition, the status analysis and maturity model may be used in the longer term as evaluation tools (e.g. by health insurance providers to fulfil their reporting obligations to the Federal Ministry of Health).

The aim of publishing the present study protocol is to promote transparency by facilitating open access to comprehensive study details that extend beyond the summary publicised in the German Clinical Trials Register. Moreover, the study protocol may serve as a point of reference to the scientific community and other parties interested in the scientific and ethical aspects of the study, and prevent unnecessary duplication.

Supporting information

S1 Checklist. STROBE statement—checklist of items that should be included in reports of observational studies–HOPAN study protocol.

(DOCX)

Acknowledgments

The authors acknowledge Valerie Appleby’s excellent editorial scrutiny of the language of the present study protocol.

Data Availability

No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.

Funding Statement

The study “HOPAN – Status exploration and analysis of regional hospice and palliative care networks using an adapted quality assessment tool” is funded (on the basis of peer review) by the Innovation Fund of the German Federal Joint Committee (G-BA) (Grant N° 01VSF22042). The grant was awarded to SvS. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Herrlein P. Handbuch Netzwerk und Vernetzung in der Hospiz- und Palliativversorgung. Theorien, Strategien, Beratungswissen. Wie spezialisierte und nicht-spezialisierte Leistungserbringer gemeinsam Schwerkranke und Sterbende versorgen. Wuppertal: der Hospiz Verlag; 2009. [Google Scholar]
  • 2.Muhlensiepen F, Thoma S, Marschke J, Heinze M, Harms D, Neugebauer EAM, et al. "If they were to stop coming, I’d panic": Palliative care networks from the perspectives of patients and informal care givers. Schmerz. 2019;33(4):320–8. [DOI] [PubMed] [Google Scholar]
  • 3.Herbst FA, Heckel M, Stiel S, Ostgathe C. Well connected—optimally cared for!: Beneficial factors of collaboration in hospice and palliative care networks in Bavaria. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz. 2017;60(1):37–44. [DOI] [PubMed] [Google Scholar]
  • 4.Herbst FA, Stiel S, Heckel M, Ostgathe C. Beschreibung und Analyse der Partner in Netzwerken der Hospiz- und Palliativversorgung in Bayern an der Schnittstelle ambulant-stationär: Eine Mixed-Methods-Studie. Zeitschrift für Palliativmedizin. 2017;18(06):310–8. [Google Scholar]
  • 5.Schwabe S, Fischer R, Herbst FA, Schleef T, Schneider N. Regionale Hospiz- und Palliativnetzwerke in Niedersachsen: Ergebnisse einer Online-Bestandserhebung und -analyse. Zeitschrift für Palliativmedizin. 2022; July 22. doi: 10.1055/a-1861-3795 [DOI] [Google Scholar]
  • 6.Bundesrat. Gesetzesbeschluss des Deutschen Bundestages. Gesetz zur Weiterentwicklung der Gesundheitsversorgung (Gesundheitsversorgungsweiterentwicklungsgesetz—GVWG). Drucksache 511/21 2021 (cited 2022 Oct 25). Available from: https://www.bundesrat.de/SharedDocs/drucksachen/2021/0501-0600/511-21.pdf?__blob=publicationFile&v=1
  • 7.Justiz Bd. Gesetz zur Verbesserung der Hospiz- undPalliativversorgung in Deutschland (Hospiz- und Palliativgesetz–HPG). Bundesgesetzblatt. 2015;48(Teil 1):2114. [Google Scholar]
  • 8.Sozialgesetzbuch (SGB) FBV. Gesetzliche Krankenversicherung—(Artikel 1 des Gesetzes v. 20. Dezember 1988, BGBl. I S. 2477) § 39d Förderung der Koordination in Hospiz- und Palliativnetzwerken durch einen Netzwerkkoordinator 2021 [cited 2022 Oct 25]. Available from: https://www.gesetze-im-internet.de/sgb_5/__39d.html
  • 9.Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): Palliativmedizin für Patienten mit einer nicht-heilbaren Krebserkrankung, Langversion 2.2, 2020, AWMF-Registernummer: 128/001OL [cited 2023 Apr 11]. Available from: https://www.leitlinienprogramm-onkologie.de/leitlinien/palliativmedizin/.
  • 10.Herbst FA, Stiel S, Heckel M, Ostgathe C. Handreichung: Netzwerke der Hospiz- und Palliativversorgung (NetHPV) in Bayern—Langfassung 2017. [cited 2022 Oct 25] Available from: https://www.dgpalliativmedizin.de/images/NetHPV_Handreichung_Langfassung.pdf. [Google Scholar]
  • 11.Radbruch L, Payne SA. White Paper on standards and norms for hospice and palliative care in Europe. Eur J Palliativ Care. 2009;16(6):278–89. [Google Scholar]
  • 12.den Herder-van der Eerden M, van Wijngaarden J, Payne S, Preston N, Linge-Dahl L, Radbruch L, et al. Integrated palliative care is about professional networking rather than standardisation of care: A qualitative study with healthcare professionals in 19 integrated palliative care initiatives in five European countries. Palliative medicine. 2018;32(6):1091–102. doi: 10.1177/0269216318758194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.den Herder-van der Eerden M, Hasselaar J, Payne S, Varey S, Schwabe S, Radbruch L, et al. How continuity of care is experienced within the context of integrated palliative care: A qualitative study with patients and family caregivers in five European countries. Palliative medicine. 2017;31(10):946–55. doi: 10.1177/0269216317697898 [DOI] [PubMed] [Google Scholar]
  • 14.Nikbakht-Van de Sande CV, van der Rijt CC, Visser AP, ten Voorde MA, Pruyn JF. Function of local networks in palliative care: a Dutch view. Journal of palliative medicine. 2005;8(4):808–16. doi: 10.1089/jpm.2005.8.808 [DOI] [PubMed] [Google Scholar]
  • 15.Morin D, Saint-Laurent L, Bresse MP, Dallaire C, Fillion L. The benefits of a palliative care network: a case study in Quebec, Canada. International journal of palliative nursing. 2007;13(4):190–6. [DOI] [PubMed] [Google Scholar]
  • 16.Vogel C, Jaeger J, Gisch D. Erfahrungen aus dem Modellprojekt „Allgemeine Ambulante PalliativVersorgung“–eine qualitative Studie. Zeitschrift für Palliativmedizin. 2019;20:39–44. [Google Scholar]
  • 17.von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–7. doi: 10.1016/S0140-6736(07)61602-X [DOI] [PubMed] [Google Scholar]
  • 18.Eymann T, Buck C, Burster S, Sarikaya S, Behrens L, Keweloh C. Reifegradmodelle zur Gestaltung und Entwicklung erfolgreicher Gesundheitsnetzwerke 2018. [cited 2022 Oct 25]. Available from: https://www.indiger.net/wp-content/uploads/2018/10/INDIGER_UNI-BT_Reifegrade.pdf. [Google Scholar]
  • 19.Landesstützpunkt Hospizarbeit und Palliativversorgung Niedersachsen. Angebote vor Ort 2021 [cited 2022 Oct 25]. Available from: https://www.hospiz-palliativ-nds.de/angebote-vor-ort/.
  • 20.Bayerisches Staatsministerium für Gesundheit und Pflege. Netzwerke in der Hospiz- und Palliativversorgung 2016 [cited 2022 Oct 25]. Available from: https://www.stmgp.bayern.de/gesundheitsversorgung/sterbebegleitung/netzwerke-in-der-hospiz-und-palliativversorgung/.
  • 21.Palliativportal. Übersichtskarte 2021 [cited 2022 Oct 25]. Available from: https://www.palliativ-portal.de/palliative/map.
  • 22.Deutsche Gesellschaft für Palliativmedizin. Wegweiser Hospiz- und Palliativversorgung Deutschland 2021 [cited 2022 Oct 25]. Available from: https://www.wegweiser-hospiz-palliativmedizin.de/.
  • 23.Mayring P. Qualitative content analysis: theoretical foundation, basic procedures and software solution. Klagenfurt; 2014. [Google Scholar]
  • 24.American Psychological Association. Ethical principles of psychologists and code of conduct. In: Sharing Research Data for Verification. US; 2010. 8.14.

Decision Letter 0

Stefan Grosek

10 Apr 2023

PONE-D-22-32383Status exploration and analysis of regional hospice and palliative care networks in Germany: A protocol for a mixed-methods studyPLOS ONE

Dear Dr. Schwabe,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

ACADEMIC EDITOR: 

  • Please find some minor comments from the 2nd reviewer which need to be addressed in the article.

  • No conflicts between both reviews were found.

Please submit your revised manuscript by May 12 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Stefan Grosek, Ph.D., M.D.,

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments:

Dear Authors

Please find some minor comments from the 2nd reviewer to be implemnted in your article. Otherwise, this is well written and concise article on status exploration and analysis of regional hospice and palliative care network in Germany.

I'm happy to receive your reply as soon as possible.

Kind regards

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does the manuscript provide a valid rationale for the proposed study, with clearly identified and justified research questions?

The research question outlined is expected to address a valid academic problem or topic and contribute to the base of knowledge in the field.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

2. Is the protocol technically sound and planned in a manner that will lead to a meaningful outcome and allow testing the stated hypotheses?

The manuscript should describe the methods in sufficient detail to prevent undisclosed flexibility in the experimental procedure or analysis pipeline, including sufficient outcome-neutral conditions (e.g. necessary controls, absence of floor or ceiling effects) to test the proposed hypotheses and a statistical power analysis where applicable. As there may be aspects of the methodology and analysis which can only be refined once the work is undertaken, authors should outline potential assumptions and explicitly describe what aspects of the proposed analyses, if any, are exploratory.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

3. Is the methodology feasible and described in sufficient detail to allow the work to be replicable?

Descriptions of methods and materials in the protocol should be reported in sufficient detail for another researcher to reproduce all experiments and analyses. The protocol should describe the appropriate controls, sample size calculations, and replication needed to ensure that the data are robust and reproducible.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

4. Have the authors described where all data underlying the findings will be made available when the study is complete?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception, at the time of publication. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

********** 

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above and, if applicable, provide comments about issues authors must address before this protocol can be accepted for publication. You may also include additional comments for the author, including concerns about research or publication ethics.

You may also provide optional suggestions and comments to authors that they might find helpful in planning their study.

(Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: the text is well written. Interesting for the readership. The text is well written. Interesting for the readership. Objective clearly set, well presented, good discussion with references

Reviewer #2: The authors present the protocol of a study examinng hospice - and specialist palliative care networks. The topic is clearly relevant for the establishment of sustainable, efficient and effective collaborations and thus, a state-of-the art cross-sectional care for patients with advanced and life-limiting diseases.

The manuscript is written in a concise, comprehensive and comprehensible manner. Syntax, semantics and wording do not leave room for improvement, but please note, that I am not a native speaker.

The relevant litarature has obviously been researched extensively and choosen meaningfully. A short search performed on my own did not yield any further relevant literature, as far as I can see on first sight.

The methodology is impeccable and checking vs equator network guidelines I could not find major shortcomings.

Yet I have two suggestions:

a) The authors write about "palliative care", also in the title. I believe it should be made clear, that this is rather "specialist palliative care" or "joint general and specialist palliative care". Please consider rewording after discussion in your author group

b) The definition of "hospice" is differing between different international health care settings. You may consider clarifying this not also in the introduction, but even though this is iterative, in the discussion. Please feel free to ignore this suggestion, if your author group (at least the key- authors) agrees to do so after thourough discussion.

********** 

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: PONE-D-22-32383.pdf

PLoS One. 2023 Jun 2;18(6):e0286583. doi: 10.1371/journal.pone.0286583.r002

Author response to Decision Letter 0


4 May 2023

In the introduction, it was added that the networks include all providers of general and specialised palliative care in the outpatient and inpatient sector.

In the introduction, the term "hospice" in Germany was explained and the hospice care structures were described, referring to the S3- Leitlinie “Palliativmedizin für Patienten mit einer nicht-heilbaren Krebserkrankung”

Attachment

Submitted filename: 2023_04_11 Response to Reviewers_HOPAN.docx

Decision Letter 1

Stefan Grosek

19 May 2023

Status exploration and analysis of regional hospice and palliative care networks in Germany: A protocol for a mixed-methods study

PONE-D-22-32383R1

Dear Dr. Schwabe,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Stefan Grosek, Ph.D., M.D.,

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Acceptance letter

Stefan Grosek

24 May 2023

PONE-D-22-32383R1

Status exploration and analysis of regional hospice and palliative care networks in Germany: A protocol for a mixed-methods study

Dear Dr. Schwabe:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Professor Stefan Grosek

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. STROBE statement—checklist of items that should be included in reports of observational studies–HOPAN study protocol.

    (DOCX)

    Attachment

    Submitted filename: PONE-D-22-32383.pdf

    Attachment

    Submitted filename: 2023_04_11 Response to Reviewers_HOPAN.docx

    Data Availability Statement

    No datasets were generated or analysed during the current study. All relevant data from this study will be made available upon study completion.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES